Sanbio B.V.

Sanbio B.V. company information, Employees & Contact Information

Explore related pages

Related company profiles:

As an independent distributor and manufacturer of life science products and services for research and diagnostics, we strive to build long-term relationships with both our clients and suppliers. In accomplishing our mission, it is our experience that knowledge makes the difference. Sanbio is part of Europa Biosite, a European supplier of life science products and services. We are a group of six leading distribution companies: Biomol in Germany, Cambridge Bioscience in the UK and Ireland, LubioScience in Switzerland, Nordic BioSite in the Nordics and Baltics, Sanbio in Benelux and Szabo-Scandic in Austria. The group has a portfolio of over 5 million products, representation in 15 European countries and a highly skilled team of over 150 employees.

Company Details

Employees
16
Founded
-
Address
Frontstraat 2c, Postbus 540,netherlands
Phone
31 413 251115
Email
su****@****nbio.nl
Industry
Biotechnology
Website
sanbio.nl
HQ
UDEN
Looking for a particular Sanbio B.V. employee's phone or email?

Sanbio B.v. Questions

News

SanBio Awaits Regulatory Decision on AKUUGO Suspension - TipRanks

SanBio Awaits Regulatory Decision on AKUUGO Suspension TipRanks

SanBio Stock Surge: A New Hope in Brain Injury Treatment - Meyka

SanBio Stock Surge: A New Hope in Brain Injury Treatment Meyka

SanBio Co. Reports Losses Amid R&D Investments - TipRanks

SanBio Co. Reports Losses Amid R&D Investments TipRanks

SanBio Obtains Marketing Approval for "AKUUGO® Suspension for Intracranial Implantation" (INN: Vandefitemcel) as a Therapeutic Agent for Improving Chronic Motor Paralysis From Traumatic Brain Injury (TBI) - Yahoo Finance

SanBio Obtains Marketing Approval for "AKUUGO® Suspension for Intracranial Implantation" (INN: Vandefitemcel) as a Therapeutic Agent for Improving Chronic Motor Paralysis From Traumatic Brain Injury (TBI) Yahoo Finance

SanBio publishes interim data from traumatic brain injury trial - Clinical Trials Arena

SanBio publishes interim data from traumatic brain injury trial Clinical Trials Arena

Japan’s Sanbio submits BLA for brain injury regenerative therapy under Sakigake designation system - BioWorld MedTech

Japan’s Sanbio submits BLA for brain injury regenerative therapy under Sakigake designation system BioWorld MedTech

SanBio Awarded RMAT for SB623, a Modified Stem Cell Treatment for TBI - BioInformant

SanBio Awarded RMAT for SB623, a Modified Stem Cell Treatment for TBI BioInformant

Top Sanbio B.V. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant